FDA Approves Cabometyx for Advanced RCC

Most clear cell RCC tumors have lower-than-normal levels or function of the von Hippel-Lindau protein, which leads to higher levels of MET signaling protein, a single-pass tyrosine kinase receptor; AXL gene; and vascular endothelial growth factor (VEGF). Higher-than-normal levels of these proteins can promote